Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1999
08/26/1999WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999WO1999042589A2 Insecticidal toxins from photorhabdus
08/26/1999WO1999042588A2 Group b streptococcus antigens
08/26/1999WO1999042587A1 Pollen specific promoter
08/26/1999WO1999042586A2 Exo1 and exo2, exocytotic proteins
08/26/1999WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999WO1999042583A1 Connective tissue growth factor homologs
08/26/1999WO1999042582A1 Ammaid, a g protein coupled receptor
08/26/1999WO1999042581A1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
08/26/1999WO1999042580A2 Gaba receptors and their uses
08/26/1999WO1999042579A2 Caf1-related protein
08/26/1999WO1999042578A2 Modulation of cell proliferation, methods and reagents
08/26/1999WO1999042577A2 Biotin-binding receptor molecules
08/26/1999WO1999042576A1 Cerebellin-2 related polypeptides and dna coding therefor
08/26/1999WO1999042575A2 Calcium-activated potassium channel beta subunit gene and protein
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999WO1999042571A1 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1
08/26/1999WO1999042570A1 Cellular flip compositions for treatment of arteriosclerotic disorders
08/26/1999WO1999042569A1 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
08/26/1999WO1999042487A1 Process for concentrating protein with disease-related conformation
08/26/1999WO1999042486A1 Method of producing mouse and human endostatin
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042484A1 Fishboy, a g-protein coupled receptor
08/26/1999WO1999042483A1 Agents for the prevention of damages caused by stress conditions
08/26/1999WO1999042482A1 Methods for treatment of diabetes using peptide analogues of insulin
08/26/1999WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF
08/26/1999WO1999042480A1 Analgesic peptides from venom of grammostola spatulata and use thereof
08/26/1999WO1999042479A1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis
08/26/1999WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32
08/26/1999WO1999042477A2 Transporter protein for saccharide-coupled medicaments
08/26/1999WO1999042474A2 Method for designing dna-binding proteins of the zinc-finger class
08/26/1999WO1999042473A1 Inhibition of toxin translocation
08/26/1999WO1999042472A1 Heat shock fusion-based vaccine system
08/26/1999WO1999042470A1 Secreted proteins and polynucleotides encoding them
08/26/1999WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
08/26/1999WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor
08/26/1999WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999WO1999042127A2 Receptor derived peptides as modulators of receptor activity
08/26/1999WO1999042126A1 Recombinant fibronectin-based extracellular matrix for wound healing
08/26/1999WO1999042121A1 Modified heat shock protein-antigenic peptide complex
08/26/1999WO1999042119A1 Antimicrobial peptides and derived metapeptides
08/26/1999WO1999042118A2 Compounds and methods for diagnosis of tuberculosis
08/26/1999WO1999042090A2 Treating cancer
08/26/1999WO1999042077A2 Compositions and methods for regulating lymphocyte activation
08/26/1999WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999WO1999042075A2 Antibodies against human cd40
08/26/1999WO1999041985A1 P53-dependent secretion of growth inhibitory factors
08/26/1999WO1999041978A1 Performance enhancement
08/26/1999WO1999041974A1 Methods for improving seeds
08/26/1999WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999WO1999032628A3 Wip, a wasp-associated protein
08/26/1999WO1999031257A3 Protein expression in baculovirus vector expression systems
08/26/1999WO1999031229A3 Peptides and nucleic acids derived from eisenia foetida and the use thereof
08/26/1999WO1999031136A3 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells
08/26/1999WO1999029906A3 Gene family with transformation modulating activity
08/26/1999WO1999029844A3 Novel retroelements zam and idemfix, and their integrase
08/26/1999WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/26/1999WO1999029720A3 Mammalian alpha helical protein-1
08/26/1999WO1999029159B1 Plant senescence-associated genes
08/26/1999WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999027954A3 Mixed lipopeptide micelles for inducing an immune response
08/26/1999WO1999027094A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
08/26/1999WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/26/1999WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers
08/26/1999WO1999023113A3 Rho family antagonists and their use to block inhibition of neurite outgrowth
08/26/1999WO1999021965A3 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
08/26/1999WO1999020774A3 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
08/26/1999WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides
08/26/1999WO1999004265A3 Cancer associated nucleic acids and polypeptides
08/26/1999WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors
08/26/1999DE19807265A1 New adenoviral vector useful for gene therapy
08/26/1999DE19753753A1 New recombinant nucleic acid encoding proteins for modifying effects of cytokine systems, e.g. for treating infection or trauma
08/26/1999CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
08/26/1999CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999CA2322617A1 Compounds and methods for diagnosis of tuberculosis
08/26/1999CA2322200A1 Receptor derived peptides as modulators of receptor activity
08/26/1999CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
08/26/1999CA2321958A1 Method of producing mouse and human endostatin
08/26/1999CA2321929A1 Methods for treatment of diabetes using peptide analogues of insulin
08/26/1999CA2321482A1 Treating cancer
08/26/1999CA2321481A1 Treating cancer
08/26/1999CA2321480A1 Treating cancer
08/26/1999CA2321479A1 Treating cancer
08/26/1999CA2321467A1 Treating cancer
08/26/1999CA2321458A1 Treating cancer
08/26/1999CA2321438A1 Treating cancer
08/26/1999CA2321262A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
08/26/1999CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
08/26/1999CA2321199A1 Compositions and methods for regulating lymphocyte activation
08/26/1999CA2321197A1 Agents for the prevention of damages caused by stress conditions
08/26/1999CA2321196A1 Recombinant active human zona pellucida protein 3 (hzp3)
08/26/1999CA2321186A1 Apoptosis inducing molecule ii and methods of use
1 ... 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 ... 2916